The Intestinal Microbiome and the Metabolic Syndrome—How Its Manipulation May Affect Metabolic-Associated Fatty Liver Disease (MAFLD)

por Malnick, Stephen D. H., Ohayon Michael, Sheral
Publicado 2023

Manipulation of the intestinal microbiome-a slow journey to primetime

por Kriger-Sharabi, Ofra, Malnick, Stephen D H, Fisher, David
Publicado 2023

Checkpoint Inhibitors and Hepatotoxicity

por Malnick, Stephen D. H., Abdullah, Ali, Neuman, Manuela G.
Publicado 2021

Treatment of Chronic Hepatitis C in the Aged – Does It Impact Life Expectancy? A Decision Analysis

por Maor, Yaakov, Malnick, Stephen D. H., Melzer, Ehud, Leshno, Moshe
Publicado 2016

Treating the Metabolic Syndrome by Fecal Transplantation—Current Status

por Malnick, Stephen D. H., Fisher, David, Somin, Marina, Neuman, Manuela G.
Publicado 2021

Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different

por Malnick, Stephen D. H., Alin, Pavel, Somin, Marina, Neuman, Manuela G.
Publicado 2022

Liraglutide-Induced Hepatotoxicity

por Maor, Yaakov, Ergaz, David, Malnick, Stephen D. H., Melzer, Ehud, Neuman, Manuela G.
Publicado 2021